Fig. 5From: Assessing neutrophil-derived ROS production at the bedside: a potential prognostic tool in severe COVID-19 casesTrajectories of LIT scores vs days from admission for survivors (left) and non-survivors (right). These graphs highlight the distinct difference in trajectories of LIT scores between patients with different outcomes, specifically survivors and non-survivors. In particular, non-survivors generally maintained higher LIT scores (> 1000 RLUs) for longer periods compared with survivorsBack to article page